Providers

Latest News

Semaglutide injections | Image credit: Patrick Bay Damsted – stock.adobe.com
Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD

May 24th 2024

Patients who took the weekly glucagon-like peptide 1 (GLP-1) receptor agonist were 21% less likely to experience major kidney disease events and 29% less likely to die due to cardiovascular causes.

Concept of hidradenitis suppurativa | Image credit: syahrir - stock.adobe.com
Bimekizumab Elicits Clinically Meaningful Responses in Moderate to Severe Hidradenitis Suppurativa

May 24th 2024

Doctor checking person's leg for muscle weakness | Image credit: Danai - stock.adobe.com
Glucocorticoids Reduce Comorbidity Frequency in Adults With DMD, Study Finds

May 23rd 2024

Young diverse people having fun using mobile phones outdoor in the city | Image Credit: Focus on gay man hand - Vane Nunes - stock.adobe.com
Study Challenges Rapid-Onset Gender Dysphoria Claims With Longitudinal Data

May 23rd 2024

People exercising | Image Credit: flamingo images-stock.adobe.com
Aerobic Cooldown Has Limited Impact on Hyperglycemia in Type 1 Diabetes

May 23rd 2024

More News

CH LogoCenter for Biosimilars Logo